Current status of recanalization therapy in acute ischemic stroke with symptomatic intracranial arterial occlusion in Korea

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 5, 2014, Pages

  Jang, Min Uk ^a   Hong, Jeong Ho ^b   Kang, Jihoon ^b   Kim, Beom Joon ^b   Han, Moon Ku ^b   Lee, Byung Chul ^a   Yu, Kyung Ho ^a   Oh, Mi Sun ^a   Hong, Keun Sik ^c   Cho, Yong Jin ^c   Park, Jong Moo ^d   Kang, Kyusik ^d   Cha, Jae Kwan ^e   Kim, Dae Hyun ^e   Park, Tai Hwan ^f   Lee, Kyung Bok ^g   Lee, Soo Joo ^h   Ko, Youngchai ^h   Lee, Jun ⁱ   Cho, Ki Hyun ^j   Kim, Joon Tae ^j   Lee, Juneyoung ^k   Lee, Ji Sung ^g   Bae, Hee Joon ^b   more..

^a Hallym University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Inje University   (South Korea)

^d Eulji General Hospital   (South Korea)

^e Dong A University College of Medicine   (South Korea)

^f Seoul Medical Center   (South Korea)

^g Soonchunhyang University   (South Korea)

^h Eulji University   (South Korea)

ⁱ Yeungnam University Hospital   (South Korea)

^j Chonnam National University Medical School   (South Korea)

^k Korea University College of Medicine   (South Korea)

more..

Author keywords

acute ischemic stroke; endovascular treatment; intracranial arterial occlusion; Korea; outcome; Recanalization therapy; registry; thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; EMBOLIZATION COIL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCATHETER; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; SELF EXPANDING STENT; SOUTH KOREA; SYMPTOMATOLOGY; THROMBECTOMY DEVICE; TREATMENT OUTCOME; VERY ELDERLY; ARTERIAL OCCLUSIVE DISEASES; CEREBRAL ARTERIAL DISEASES; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; CONVALESCENCE; DISABILITY; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; REGISTER; RETROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICAL MODEL; STROKE; TIME; TIME TO TREATMENT; TRENDS;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; BRAIN ISCHEMIA; CEREBRAL ARTERIAL DISEASES; DISABILITY EVALUATION; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; RECOVERY OF FUNCTION; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84901340297     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.12.027     Document Type: Article

References (26)

1. D.L. Brown, K.C. Johnston, and D.P. Wagner et al. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke Stroke 35 2004 147 150
2. W.S. Smith, J.W. Tsao, and M.E. Billings et al. Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia Neurocrit Care 4 2006 14 17
3. J.L. Saver, R. Jahan, and E.I. Levy et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial Lancet 380 2012 1241 1249
4. R.G. Nogueira, H.L. Lutsep, and R. Gupta et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial Lancet 380 2012 1231 1240
5. M. Mazighi, J.M. Serfaty, and J. Labreuche et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study Lancet Neurol 8 2009 802 809
6. W. Hacke, M. Kaste, and E. Bluhmki et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 2008 1317 1329
7. R. Bhatia, M.D. Hill, and N. Shobha et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action Stroke 41 2010 2254 2258
8. W.S. Smith, G. Sung, and J. Saver et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial Stroke 39 2008 1205 1212
9. I.Q. Grunwald, A.K. Wakhloo, and S. Walter et al. Endovascular stroke treatment today AJNR Am J Neuroradiol 32 2011 238 243
10. A.E. Hassan, S.A. Chaudhry, and M. Grigoryan et al. National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era Stroke 43 2012 3012 3017
11. M.G. Hennerici, R. Kern, and K. Szabo Non-pharmacological strategies for the treatment of acute ischaemic stroke Lancet Neurol 12 2013 572 584
12. S. Yoshimura, Y. Egashira, and N. Sakai et al. Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism-Japan retrospective survey group. Retrospective nationwide survey of acute stroke due to large vessel occlusion in Japan: a review of 1,963 patients and the impact of endovascular treatment Cerebrovasc Dis 32 2011 219 226
13. A.C. Chao, H.Y. Hsu, and C.P. Chung et al. Outcomes of thrombolytic therapy for acute ischemic stroke in Chinese patients: the Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study Stroke 41 2010 885 890
14. B.J. Kim, M.K. Han, and T.H. Park et al. Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry Int J Stroke 2013 Nov 21 [Epub ahead of print.]
15. K.-S. Hong, O.Y. Bang, and D.-W. Kang et al. Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the Korean Stroke Society and Clinical Research Center for stroke J Stroke 15 2013 2 20
16. E.A. Noser, H.M. Shaltoni, and C.E. Hall et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 36 2005 292 296
17. R.T. Higashida, A.J. Furlan, and H. Roberts et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke Stroke 34 2003 e109 e137
18. T. Kharitonova, R. Mikulik, and R.O. Roine et al. Association of early national institutes of health stroke scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke Stroke 42 2011 1638 1643
19. V. Larrue, R.R. von Kummer, and A. Muller et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II) Stroke 32 2001 438 441
20. P. Michel, C. Odier, and M. Rutgers et al. The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging Stroke 41 2010 2491 2498
21. E.C. Jauch, J.L. Saver, and H.P. Adams Jr. et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 44 2013 870 947
22. C.S. Kidwell, R. Jahan, and J. Gornbein et al. A trial of imaging selection and endovascular treatment for ischemic stroke N Engl J Med 368 2013 914 923
23. A. Ciccone, L. Valvassori, and M. Nichelatti et al. Endovascular treatment for acute ischemic stroke N Engl J Med 368 2013 904 913
24. J.P. Broderick, Y.Y. Palesch, and A.M. Demchuk et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke N Engl J Med 368 2013 893 903
25. A. Furlan, R. Higashida, and L. Wechsler et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism JAMA 282 1999 2003 2011
26. J.H. Rha, and J.L. Saver The impact of recanalization on ischemic stroke outcome: a meta-analysis Stroke 38 2007 967 973